| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $0 | 0 | 0 |
Sells | $634,416 | 6 | 100 |
| Kelly Jason P | See Remarks | 0 | $0 | 1 | $57,347 | $-57,347 |
| Rondoni John | See Remarks | 0 | $0 | 3 | $155,309 | $-155,309 |
| mcCormick Shawn | director | 0 | $0 | 2 | $421,760 | $-421,760 |
Inspire Medical Systems, Inc. operates as a medical technology enterprise, concentrating on the development and commercialization of advanced, minimally intrusive therapies for patients diagnosed with obstructive sleep apnea (OSA) across both domestic U.S. and international markets. A cornerstone of its product portfolio is the Inspire system, an innovative neurostimulation solution that offers a safe and proven effective treatment for individuals experiencing moderate to severe forms of OSA. Additionally, the company is pioneering a novel, …
Over the last 12 months, insiders at Inspire Medical Systems, Inc. have bought $0 and sold $634,416 worth of Inspire Medical Systems, Inc. stock.
On average, over the past 5 years, insiders at Inspire Medical Systems, Inc. have bought $8,077 and sold $39.74M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 1 shares for transaction amount of $148 was made by Curet Myriam (director) on 2025‑04‑07.
| 2026-08-07 | Sale | Kelly Jason P | See Remarks | 963 0.0033% | $59.55 | $57,347 | +14.35% | |
| 2026-05-15 | Sale | Rondoni John | See Remarks | 2,641 0.0099% | $43.28 | $114,302 | +47.34% | |
| 2026-05-14 | Sale | Rondoni John | See Remarks | 700 0.0024% | $43.01 | $30,107 | +38.05% | |
| 2026-01-09 | Sale | Rondoni John | See Remarks | 109 0.0004% | $100.00 | $10,900 | -40.76% | |
| 2025-12-02 | Sale | mcCormick Shawn | director | 1,200 0.0042% | $139.00 | $166,800 | -55.22% | |
| 2025-11-28 | Sale | mcCormick Shawn | director | 2,000 0.0069% | $127.48 | $254,960 | -51.70% | |
| 2025-08-29 | Sale | Buchholz Richard | Chief Financial Officer | 11,000 0.0371% | $93.39 | $1.03M | -34.10% | |
| 2025-08-08 | Sale | Curet Myriam | director | 4 <0.0001% | $77.28 | $309 | -14.08% | |
| 2025-05-19 | Sale | Rondoni John | See Remarks | 1,734 0.0059% | $149.38 | $259,025 | -44.72% | |
| 2025-05-08 | Sale | Curet Myriam | director | 2 <0.0001% | $153.22 | $306 | -45.15% | |
| 2025-05-02 | Sale | mcCormick Shawn | director | 360 0.0012% | $160.00 | $57,600 | -46.62% | |
| 2025-04-07 | Curet Myriam | director | 1 <0.0001% | $148.26 | $148 | -38.38% | ||
| 2025-03-20 | Curet Myriam | director | 4 <0.0001% | $163.84 | $655 | -41.93% | ||
| 2025-03-03 | Sale | Rondoni John | Chief Technology Officer | 2,287 0.0078% | $185.60 | $424,467 | -46.32% | |
| 2025-03-03 | Sale | Ban Randy | See Remarks | 3,947 0.0136% | $185.84 | $733,496 | -46.32% | |
| 2025-02-13 | Sale | Ban Randy | See Remarks | 25,584 0.0846% | $183.50 | $4.69M | -32.49% | |
| 2025-02-11 | Sale | Rondoni John | Chief Technology Officer | 583 0.0018% | $170.49 | $99,396 | -31.02% | |
| 2025-01-07 | Sale | Rondoni John | Chief Technology Officer | 58 0.0002% | $215.00 | $12,470 | -39.32% | |
| 2024-11-01 | Sale | Rondoni John | Chief Technology Officer | 8,703 0.0296% | $193.47 | $1.68M | -21.51% | |
| 2024-09-09 | Sale | McCormick Shawn | director | 800 0.0028% | $220.00 | $176,000 | -19.40% |
| mcCormick Shawn | director | 24846 0.0859% | $1.54M | 1 | 4 | +89.73% |
| Amzak Health Investors, LLC | 10 percent owner | 1497043 5.1782% | $92.67M | 1 | 0 | +89.73% |
| Erony Joyce | director | 103939 0.3595% | $6.43M | 1 | 39 | +89.73% |
| Herbert Timothy P. | CEO and President | 63658 0.2202% | $3.94M | 1 | 30 | +89.73% |
| NELSON MARILYN C | director | 50919 0.1761% | $3.15M | 1 | 19 | +89.73% |
| Buchholz Richard | Chief Financial Officer | 44867 0.1552% | $2.78M | 1 | 20 | +89.73% |
| Mead Dana G Jr. | director | 20000 0.0692% | $1.24M | 1 | 0 | +89.73% |
| Tansey Casey M | director | 18830 0.0651% | $1.17M | 1 | 4 | +89.73% |
| Ban Randy | See Remarks | 7259 0.0251% | $449,332.10 | 1 | 36 | +89.73% |
| Jandrich Steven | VP, Human Resources | 4371 0.0151% | $270,564.90 | 1 | 10 | +89.73% |
| Curet Myriam | director | 3365 0.0116% | $208,293.50 | 2 | 2 | <0.0001% |
| Sparks Charisse Y | Chief Medical Officer | 998 0.0035% | $61,776.20 | 1 | 0 | +25.74% |
| ORBIMED ADVISORS LLC | director | 0 0% | $0 | 1 | 15 | +89.73% |
| Khuong Chau Quang | director | 0 0% | $0 | 1 | 16 | +89.73% |
| Increased Positions | 213 | +54.48% | 11M | +36.46% |
| Decreased Positions | 185 | -47.31% | 8M | -26.88% |
| New Positions | 93 | New | 5M | New |
| Sold Out Positions | 71 | Sold Out | 3M | Sold Out |
| Total Postitions | 419 | +7.16% | 34M | +9.58% |
| Blackrock, Inc. | $327,300.00 | 12.23% | 3.55M | -326,591 | -8.43% | 2025-09-30 |
| Vanguard Group Inc | $276,818.00 | 10.35% | 3M | -203,504 | -6.35% | 2025-09-30 |
| Citadel Advisors Llc | $161,326.00 | 6.03% | 1.75M | +2M | +20,054.57% | 2025-09-30 |
| William Blair Investment Management, Llc | $119,727.00 | 4.47% | 1.3M | +528,404 | +68.7% | 2025-09-30 |
| Baillie Gifford & Co | $100,053.00 | 3.74% | 1.08M | -29,538 | -2.65% | 2025-09-30 |
| Deerfield Management Company, L.P. | $96,671.00 | 3.61% | 1.05M | +907,694 | +648.35% | 2025-09-30 |
| State Street Corp | $90,361.00 | 3.38% | 979,309 | -51,593 | -5% | 2025-09-30 |
| Braidwell Lp | $81,543.00 | 3.05% | 883,747 | +361,337 | +69.17% | 2025-09-30 |
| Ubs Am, A Distinct Business Unit Of Ubs Asset Management Ame | $76,916.00 | 2.87% | 833,599 | +225,291 | +37.04% | 2025-09-30 |
| Fmr Llc | $69,139.00 | 2.58% | 749,312 | -2M | -67.22% | 2025-09-30 |